Enter assignee name

% Expired Patents = 75.0

Forward Citations = 40

Loading Chart...

8 inventors (with patents filed for the assignee):

Matthew J During (5 out of 68 patents)

Michael G Kaplitt (4 out of 14 patents)

Helen Fitzsimons (2 out of 2 patents)

4. Ross Bland (2 out of 2 patents)

5. Weidong Xiao (1 out of 13 patents)

6. Serguei Moussatov (1 out of 1 patent)

7. Annamaria Vezzani (1 out of 1 patent)

8. Lei Cao (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 8071563 - Glutamic acid decarboxylase (GAD) chimera and methods of use (2011-12-06),

2. 8017385 - Use of apotosis inhibiting compounds in degenerative neurological disorders (2011-09-13),

3. 7955595 - Glutamic acid decarboxylase (GAD) based delivery system (2011-06-07),

4. 7723288 - Methods and compositions for the treatment of neurological disease (2010-05-25),

5. 7695959 - Glutamic acid decarboxylase (GAD) based delivery systems (2010-04-13),

6. 7645446 - Glutamic acid decarboxylase (GAD) based delivery system (2010-01-12),

7. 7527785 - Glutamic acid decarboxylase (GAD) chimera and methods of use (2009-05-05),

8. 6329181 - Helper functions for recombinant vector production (2001-12-11),

Neurologix, Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapies for neurological disorders. With a focus on gene therapy, Neurologix is at the forefront of revolutionizing treatments for conditions such as Parkinson's disease and epilepsy. Through cutting-edge research and a commitment to improving patient outcomes, Neurologix aims to make a significant impact in the field of neurology.

Profile summary based on public USPTO records.